Target intelligence / Profile preview

Glycolysis-related enzyme

Molecular classification
Enzyme, Kinase, Mutase, Isomerase, Dehydrogenase, Lyase, Transferase
01

Overview

Glycolysis-related enzymes are a group of metabolic proteins that catalyze the reactions converting glucose into pyruvate within the cytosol, generating ATP and NADH for cellular energy and biosynthetic precursor production[8][10]. These include Hexokinase, Phosphofructokinase, Aldolase, Isomerase, Dehydrogenase, Kinase, Mutase, Enolase, and Pyruvate kinase[4][8][6]. Dysregulation, isoform variation, and overexpression of these enzymes are critical for the altered metabolism seen in cancer and other diseases, making them valuable therapeutic targets[1][9][7][5]. Because "Glycolysis-related enzymes" refers to a collective pathway and not a single target, the term is broad and not suitable for entry as a single canonical molecule. This entry is not specific to a single canonical protein, so detailed structured information for molecular databases should use one specific enzyme from the glycolytic pathway rather than the class as a whole[1][8][4].

Other names
Glycolytic enzymesenzymes of glycolysisglycolytic pathway enzymes
02

Mechanism of action

Inhibition of glycolytic enzyme activity (e.g., hexokinase inhibition reduces ATP production) Modulation of metabolic flux (shifting from glycolysis to oxidative phosphorylation) Interference with regulatory pathways (e.g., HIF-1α signaling and downstream glycolysis modulation)

03

Biological functions

Energy production (ATP synthesis)Glucose metabolismCellular bioenergeticsRegulation of cell survival and proliferationSignal transduction (through metabolic intermediates)
04

Disease associations

Cancer (tumor metabolism and proliferation)Inflammation (rheumatoid arthritis, autoimmune disease)Cardiovascular disease (pulmonary hypertension)Neurodegenerative disease (biomarkers and therapy)Infection (parasitic metabolism and potential interventions)
05

Safety considerations

Toxicity from broad metabolic inhibition leading to fatigue, gastrointestinal disturbances, and possible multi-organ effectsAdaptive metabolic bypasses reducing drug efficacySystemic metabolic disruption if non-tumor tissues are affected
06

Interacting drugs

2-Deoxy-D-glucose (2-DG)

6 more in the full profile.

07

Biomarkers

Enhanced expression or activity of Hexokinase, Phosphofructokinase, Pyruvate kinase, PFKFB3, GLUT1Lactate production

Beyond the preview

Go deeper on Glycolysis-related enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycolysis-related enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call